Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 expected total revenue guidance between $500 million to $530 million, Crysvita revenue of $375 million to $400 million, and Dojolvi revenue of $75 million to $80 million Presented positive interim Phase 1/2 data from GTX-102 Angelman syndrome study demonstrating that Expansion Cohorts showed rapid, clinically meaningful improvement across multiple domains consistent with or exceeding D...
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2024 financial results and operational highlights in a conference call on May 9, 2024, at 8 a.m. ET. To join the call: U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the c...
HII Reports First Quarter 2024 Results Record first quarter revenues of $2.8 billion, up 4.9% compared to first quarter 2023Operating income of $154 million, up 9.2% compared to first quarter 2023Net earnings of $153 million or $3.87 diluted earnings per shareNew contract awards of $3.1 billion, resulting in backlog of $48.4 billionCompany reaffirms previously issued financial guidance1 NEWPORT NEWS, Va., May 02, 2024 (GLOBE NEWSWIRE) -- HII (NYSE: HII) reported first quarter 2024 revenues of $2.8 billion, up 4.9% from the first quarter of 2023, driven primarily by growth at its Mission ...
HII’s Ingalls Shipbuilding Hosts “Signing Day” for 2024 Graduates of Shipbuilder Academy PASCAGOULA, Miss., May 01, 2024 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Ingalls Shipbuilding division hosted a “signing day” for the 2024 graduates of its Shipbuilder Academy today at the shipyard. This year, 25 talented high school students were offered full-time positions at Ingalls, where they will begin their shipbuilding career following the completion of their education. Through hands-on training, mentorship, and classroom instruction, participants in the Ingalls Shipbuilding Academy (ISA) ga...
A director at Westinghouse Air Brake Technologies Corporation sold 6,000 shares at 162.735USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Brunswick Corporation Announces Quarterly Dividend METTAWA, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Brunswick Corporation (NYSE: BC) has approved a quarterly dividend on its common stock of $0.42 per share. The dividend will be payable on June 14, 2024, to shareholders of record at the close of business on May 13, 2024. About Brunswick Corporation: Brunswick Corporation (NYSE: BC) is the global leader in marine recreation, delivering innovation that transforms experiences on the water and beyond. Our unique, technology-driven solutions are informed and inspir...
HII Declares Quarterly Dividend NEWPORT NEWS, Va., May 01, 2024 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.30 per share, payable on June 14, 2024, to shareholders of record as of the close of business on May 31, 2024. About HII HII is a global, all-domain defense provider. HII’s mission is to deliver the world’s most powerful ships and all-domain solutions in service of the nation, creating the advantage for our customers to protect peace and freedom around the world. As the nation’s largest military ship...
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story Busy is getting candid about navigating her ADHD diagnosis and treatment experience with Qelbree®The percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled in just two years (2020-2022)1Although symptoms are present in childhood, a significant portion of women with ADHD don’t receive a diagnosis until they are adults2 ROCKVILLE, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Actress, author, podcaster, and mother of two, Busy Philipps is teaming up with Supernus Pharmaceuticals ...
Two Directors at General Dynamics Corp sold 63,417 shares at between 284.501USD and 288.511USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Two Directors at Helmerich & Payne Inc sold 25,910 shares at between 40.220USD and 40.490USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024 Sales of $575 million, down five percent from the prior-year quarterNet income (including discontinued operations) of $120 million, or $2.39 per diluted shareIncome from continuing operations of $121 million, or $2.40 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $64 million, or $1.27 per diluted shareAdjusted EBITDA of $126 millionCash flows provided by operating activities of $54 million; ongoing free cash...
Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease NOVATO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today released its 2023 Corporate Responsibility Report, which showcases the company’s efforts to transform the lives of individuals and families impacted by rare and ultrarare diseases, empower its employees, and make a meaningful impact on the communities it partners with. “In rare disease, corporate responsibility means pushing for progress and change t...
Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI) NOVATO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that all patients have been enrolled across the Phase 3 Orbit and Cosmic studies evaluating setrusumab (UX143) in pediatric and young adult patients with osteogenesis imperfecta (OI). The pivotal Phase 3 portion of the Orbit study has randomized 158 patients ages 5 to 25 years, and the Cosmic study has completed enroll...
Five Directors at Chipotle Mexican Grill Inc sold/sold after exercising options 12,015 shares at between 3,156.279USD and 3,190.164USD. The significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.